Education
About Us
Working with TipRanks
Follow Us
Beverly JCG Ltd. (SG:9QX)
:9QX
9QX Stock Chart & Stats
Day’s Range― - ―
52-Week Range<S$0.01 - S$0.02
Previous CloseN/A
Volume4.08M
Average Volume (3M)3.89M
Market Cap
S$10.12M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.12
Next Earnings
Nov 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding919,963,870
10 Day Avg. Volume4,016,220
30 Day Avg. Volume3,886,236
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Beverly JCG Ltd. News
9QX FAQ
What was Beverly JCG Ltd.’s price range in the past 12 months?
Beverly JCG Ltd. lowest share price was <S$0.01 and its highest was S$0.02 in the past 12 months.
What is Beverly JCG Ltd.’s market cap?
Beverly JCG Ltd.’s market cap is S$10.12M.
When is Beverly JCG Ltd.’s upcoming earnings report date?
Beverly JCG Ltd.’s upcoming earnings report date is Nov 12, 2025 which is in 103 days.
How were Beverly JCG Ltd.’s earnings last quarter?
Currently, no data Available
Is Beverly JCG Ltd. overvalued?
According to Wall Street analysts Beverly JCG Ltd.’s price is currently Overvalued.
Does Beverly JCG Ltd. pay dividends?
Beverly JCG Ltd. does not currently pay dividends.
What is Beverly JCG Ltd.’s EPS estimate?
Beverly JCG Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beverly JCG Ltd. have?
Beverly JCG Ltd. has 919,963,870 shares outstanding.
What happened to Beverly JCG Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Beverly JCG Ltd.?
Currently, no hedge funds are holding shares in SG:9QX
Beverly JCG Ltd. (9QX) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Clearbridge Health Ltd.
―
iX Biopharma Ltd.
―
Asiamedic Limited
―
Pharmesis International Ltd.
―
Livingstone Health Holdings Limited
―
Ownership Overview
29.62% Insiders
―
Mutual Funds
― Other Institutional Investors
70.38% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---